Magnesium and blood pressure: A physiology-based approach 89 4 18. Zhang X, Li Y, Del Gobbo LC, et al. Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertens (Dallas, Tex 1979). 2016;68(2):324-333. doi:10.1161/HYPERTENSIONAHA.116.07664. 19. Dibaba DT, Xun P, Song Y, Rosanoff A, Shechter M, He K. The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials. Am J Clin Nutr. July 2017. doi:10.3945/ajcn.117.155291. 20. Salyer SA, Parks J, Barati MT, et al. Aldosterone regulates Na(+), K(+) ATPase activity in human renal proximal tubule cells through mineralocorticoid receptor. Biochim Biophys Acta. 2013;1833(10):2143-2152. doi:10.1016/j.bbamcr.2013.05.009. 21. Atarashi K, Matsuoka H, Takagi M, Sugimoto T. Magnesium ion: a possible physiological regulator of aldosterone production. Life Sci. 1989;44(20):1483-1489. 22. Atarashi K, Takagi M, Matsuoka H, Sugimoto T. Effects of magnesium on changes in blood pressure and plasma aldosterone induced by angiotensin II. Am J Hypertens. 1990;3(6 Pt 1):488-490. 23. Jin K, Kim TH, Kim YH, Kim YW. Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats. Korean J Intern Med. 2013;28(2):197-205. doi:10.3904/kjim.2013.28.2.197. 24. Ginn HE, Cade R, McCallum T, Fregley M. Aldosterone secretion in magnesium-deficient rats. Endocrinology. 1967;80(5):969-971. doi:10.1210/endo-80-5-969. 25. Solounias BM, Schwartz R. The effect of magnesium deficiency on serum aldosterone in rats fed two levels of sodium. Life Sci. 1975;17(8):1211-1217. 26. Resnick LM, Laragh JH, Sealey JE, Alderman MH. Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium, and plasma renin activity. N Engl J Med. 1983;309(15):888-891. doi:10.1056/NEJM198310133091504. 27. Kojima I, Kojima K, Rasmussen H. Effects of ANG II and K+ on Ca efflux and aldosterone production in adrenal glomerulosa cells. Am J Physiol. 1985;248(1 Pt 1):E36-43. 28. Turlapaty PD,Altura BM. Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle. Eur J Pharmacol. 1978;52(3-4):421-423. 29. Fischer PW, Giroux A. Effects of dietary magnesium on sodium-potassium pump action in the heart of rats. J Nutr. 1987;117(12):2091-2095. 30. Wong NL, Hu DC, Wong EF. Effect of dietary magnesium on atrial natriuretic peptide release. Am J Physiol. 1991;261(5 Pt 2):H1353-7. 31. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342(20):1478-1483. doi:10.1056/NEJM200005183422003. 32. Baia LC, Heilberg IP, Navis G, de Borst MH. Phosphate and FGF-23 homeostasis after kidney transplantation. Nat Rev Nephrol. 2015;11(11):656-666. doi:10.1038/nrneph.2015.153. 33. Salem S, Bruck H, Bahlmann FH, et al. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol. 2012;35(1):31-39. doi:10.1159/000334742. 34. Zelt JGE, McCabe KM, Svajger B, et al. Magnesium Modifies the Impact of Calcitriol Treatment on Vascular Calcification in Experimental Chronic Kidney Disease. J Pharmacol Exp Ther. 2015;355(3):451-462. doi:10.1124/jpet.115.228106.
RkJQdWJsaXNoZXIy MTk4NDMw